Drugs / D9421-C
last change Sep 2014 re-read 2 minutes ago

D9421-C

Developed for
Crohn disease
Investigated by
AstraZeneca

Trials 1 · a red edge is where a trial was stopped

2012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 3 NCT01514240 Feb 2012 → Sep 2014 Crohn disease AstraZeneca Completed No outcome recorded
Also used as a comparator or background therapy in 1 trial
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2 NCT00573469 Comparator Oct 2006 → Mar 2008 Crohn disease AstraZeneca Completed No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 2 sources stand behind the page.

FieldValueCited text
Known as D9421-C ClinicalTrials.gov intervention name — accepted as the source's own label NCT00573469
1

NCT01514240